- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2021 1

Panama 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama

CITE Title : Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama Personal Author(s) : Rojas-Bonilla, Magda;Coulliette-Salmond, Angela;Belgasmi, Hanen;Wong, Kimberly;Sayyad, Leanna;Vega, Everardo;Grimoldi, Fabian;Oberste, Mark S.;Rüttimann, Ricardo; Published Date : July 13 2021 Source : Viruses. 2021; 13(7) URL : https://stacks.cdc.gov/view/cdc/108313 Rojas-Bonilla, Magda et al. (2021). Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. 13(7). Rojas-Bonilla, Magda et al. "Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama" 13, no. 7 (2021) Rojas-Bonilla, Magda et al. "Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama" vol. 13, no. 7, 2021 Export RIS Citation Information.

:

Rojas-Bonilla, Magda ;

Coulliette-Salmond, Angela

July 13 2021 | Viruses. 2021; 13(7)

:

Environmental surveillance was recommended for risk mitigation in a novel oral polio vaccine-2 (nOPV2) clinical trial (M5-ABMG) to monitor excretion, ...

To see more results, try removing search filters or changing the search terms